Rupee appreciation would not hit badly: Granules

Excerpts from Closing Bell on CNBC-TV18 Watch the full show » RELATED NEWS Promoter stake to be 31-32% post dilution: Granules India Ridgeback Capital to invest $5.6 mn in Granules India Granules ties up with GSK Healthcare R&D Granules India posts 37% growth in net profit in Q2 FY07 Granules India: 7 dossiers ready to go commercial ALSO READ See latest News about Granules India See previous management interviews See what other Experts & Brokerages are saying about Granules India Granules India BSE | NSE 10/02/12 Are Mutual Funds betting on Granules India?

Managing Director at Granules India , C Krishna Prasad says, the forward integration on finish dosages would be completed by July this year and the net effect on our EBITDA would be increase of about 3% to about 17%.

Excerpts from CNBC-TV18's exclusive interview with C Krishna Prasad:

Q: Your company is in the process of forward integration or completing that basically consolidating the API, PFI as well as the finish dosages business when will the entire forward integration be complete and how would it ramp up your margins and your growth?

A: The forward integration on finish dosages would be completed by July this year and the net effect on our EBITDA would be an increase of about 3% to about 17%.

We already had manufacturing API and we have a plant in China and PFI is fully integrated.

Now the forward integration is on to finish dosages, solid dosages and that we expect to be completed by July.

Q: Where do you hope your consolidate margins would be for FY08 going forward once all the segments get fully integrated like you mentioned the integration on finish dosages is also complete?

A: The EBITDA for '08 would be about 15-15.5% and 09 we expect about 16% EBITDA.

Q: How much do you export. Do you see any trimming of margins because of the way in which the rupee shaping up?

A: It is definitely a concerning factor and we had a relook at our entire operation. But the good news is that about 60% or 58% of our raw material component is also imported. So we do not get hit that badly.

But for the rest of the things, I think we are already in negotiation with our customers and we should be able to get some price increases and we see that there should not be any negative effect.

Q: Any new launches that you looking at in FY08?

A: There are few products  that we should be launching another three-four products; innovate.

Q: What kind of a growth projection can you give us for the next two financial years in terms of revenues as well as the bottomline?

A: Revenues would be growing at around 50% compounded in the next two years and bottomline should be about 60-65%.